Cargando…
GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway
BACKGROUND: Glycogen synthase kinase-3β (GSK3β) expression and activity are upregulated in pancreatic cancer tissues. In our previous study, we found that stromal cell-derived factor-1/ chemokine receptor C-X-C motif chemokine receptor 4 (SDF-1α/CXCR4) upregulated matrix metalloproteinase 2 (MMP-2)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513390/ https://www.ncbi.nlm.nih.gov/pubmed/26213494 http://dx.doi.org/10.1186/s12935-015-0216-y |
_version_ | 1782382638469742592 |
---|---|
author | Ying, Xu Jing, Li Ma, Shijie Li, Qianjun Luo, Xiaoling Pan, Zhenguo Feng, Yanling Feng, Pan |
author_facet | Ying, Xu Jing, Li Ma, Shijie Li, Qianjun Luo, Xiaoling Pan, Zhenguo Feng, Yanling Feng, Pan |
author_sort | Ying, Xu |
collection | PubMed |
description | BACKGROUND: Glycogen synthase kinase-3β (GSK3β) expression and activity are upregulated in pancreatic cancer tissues. In our previous study, we found that stromal cell-derived factor-1/ chemokine receptor C-X-C motif chemokine receptor 4 (SDF-1α/CXCR4) upregulated matrix metalloproteinase 2 (MMP-2) and promoted invasion in PANC1 and SW-1990 pancreatic cancer cells by activating p38 mitogen-activated protein kinase (p38 MAPK). Additionally, inhibition of GSK3β reduced MMP-2 secretion. METHODS: To investigate the molecular mechanism of GSK3β in pancreatic cancer tissues, we created stable PANC1 cells up-regulation of GSK3β by transfecting GSK3β overexpression plasmid, and down-regulation of GSK3β using two different types of RNA interference. RESULTS: Western blotting showed that overexpression of GSK3β up-regulated CXCR4 and MMP-2 expression; suppression of GSK3β down-regulated CXCR4 and MMP-2 protein expression. Up-regulation of MMP2 induced by overexpression of GSK3β was blocked by inhibition of CXCR4. Overexpression of GSK3β promoted PANC1 cell invasion, and down-regulation of GSK3β suppressed PANC1 cell invasion in the transwell invasion assays. However, inhibition of CXCR4 using shRNA attenuated the ability of GSK3β to promote PANC1 cell invasion. CONCLUSIONS: This study demonstrated that GSK3β promotes PANC1 cell invasion via the CXCR4/MMP-2 pathway. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-015-0216-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4513390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45133902015-07-25 GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway Ying, Xu Jing, Li Ma, Shijie Li, Qianjun Luo, Xiaoling Pan, Zhenguo Feng, Yanling Feng, Pan Cancer Cell Int Primary Research BACKGROUND: Glycogen synthase kinase-3β (GSK3β) expression and activity are upregulated in pancreatic cancer tissues. In our previous study, we found that stromal cell-derived factor-1/ chemokine receptor C-X-C motif chemokine receptor 4 (SDF-1α/CXCR4) upregulated matrix metalloproteinase 2 (MMP-2) and promoted invasion in PANC1 and SW-1990 pancreatic cancer cells by activating p38 mitogen-activated protein kinase (p38 MAPK). Additionally, inhibition of GSK3β reduced MMP-2 secretion. METHODS: To investigate the molecular mechanism of GSK3β in pancreatic cancer tissues, we created stable PANC1 cells up-regulation of GSK3β by transfecting GSK3β overexpression plasmid, and down-regulation of GSK3β using two different types of RNA interference. RESULTS: Western blotting showed that overexpression of GSK3β up-regulated CXCR4 and MMP-2 expression; suppression of GSK3β down-regulated CXCR4 and MMP-2 protein expression. Up-regulation of MMP2 induced by overexpression of GSK3β was blocked by inhibition of CXCR4. Overexpression of GSK3β promoted PANC1 cell invasion, and down-regulation of GSK3β suppressed PANC1 cell invasion in the transwell invasion assays. However, inhibition of CXCR4 using shRNA attenuated the ability of GSK3β to promote PANC1 cell invasion. CONCLUSIONS: This study demonstrated that GSK3β promotes PANC1 cell invasion via the CXCR4/MMP-2 pathway. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-015-0216-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-05 /pmc/articles/PMC4513390/ /pubmed/26213494 http://dx.doi.org/10.1186/s12935-015-0216-y Text en © Ying et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Primary Research Ying, Xu Jing, Li Ma, Shijie Li, Qianjun Luo, Xiaoling Pan, Zhenguo Feng, Yanling Feng, Pan GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title | GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title_full | GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title_fullStr | GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title_full_unstemmed | GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title_short | GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway |
title_sort | gsk3β mediates pancreatic cancer cell invasion in vitro via the cxcr4/mmp-2 pathway |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513390/ https://www.ncbi.nlm.nih.gov/pubmed/26213494 http://dx.doi.org/10.1186/s12935-015-0216-y |
work_keys_str_mv | AT yingxu gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT jingli gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT mashijie gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT liqianjun gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT luoxiaoling gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT panzhenguo gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT fengyanling gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway AT fengpan gsk3bmediatespancreaticcancercellinvasioninvitroviathecxcr4mmp2pathway |